Thu, Apr 25, 2024
Glenmark Life Sciences Q4: Revenue from operations declined to Rs 536 crore for the period under review from Rs 621 crore a year ago
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.